70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Skandinavischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
12.05. - 15.05.2019, Würzburg
ePoster Montag, 13.05.2019
Neurochirurgische Onkologie I/Neurosurgical oncology I
Meeting Abstract
(P047)
[Volltext]
Proliferation and tumour expansion are associated with COX2 expression but not with ASA intake
Behling F, Ries V, Skardelly M, Gepfner-Tuma I, Schuhmann M, Ebner F, Tabatabai G, Schittenhelm J, Bornemann A, Tatagiba M[Volltext]
Meeting Abstract
(P048)
[Volltext]
Correlation of molecular tumour markers and tumour localisation in low-grade and grade III gliomas
Knapp PG, Gempt J, Meyer H, Ketterer C, Wasmeier AM[Volltext]
Meeting Abstract
(P049)
[Volltext]
The CXCR2/CXCL2/CXCL8 signalling pathway in glioblastoma multiforme patients in the development of resistance
Urbantat RM, Acker G, Brandenburg S, Vajkoczy P[Volltext]
Meeting Abstract
(P050)
[Volltext]
Integrity of (b)lood-(o)xygen-(l)evel)-(d)ependent signal of language associated brain activation depending on tumour proximity and radiological tumour growth patterns in patients with glioblastoma
Rosengarth K, Hense K, Wiesinger I, Ott C, Doenitz C, Brawanski A, Wendl C[Volltext]
Meeting Abstract
(P051)
[Volltext]
Comparison of outcome parameters using 60 Hz stimulation vs. monopolar stimulation in patients operated on eloquently located glioblastoma – a retrospective monocentric study
Suresh MP, Hibbe H, Rapp M, Kamp MA, Fischer I, Sabel M[Volltext]
Meeting Abstract
(P052)
[Volltext]
CUSP9* elicits significant anti-cancer activity against glioblastoma cells in vitro
Halatsch ME, Kast RE, Dwucet A, Heiland T, Siegelin MD, Wirtz CR, Karpel-Massler G[Volltext]
Meeting Abstract
(P053)
[Volltext]
Bcl-2/Bcl-xL inhibition synergistically enhances the anti-neoplastic activity of CUSP9v3 against glioblastoma cells in vitro
Halatsch ME, Kast RE, Dwucet A, Hlavac M, Heiland T, Westhoff MA, Siegelin MD, Wirtz CR, Karpel-Massler G[Volltext]
Meeting Abstract
(P054)
[Volltext]
Metabolic reprogramming following a combined treatment with imipridones and 2-deoxyglucose elicits energy depletion and synergistic anti-glioblastoma activity
Pruss M, Dwucet A, Westhoff MA, Hlavac M, Siegelin MD, Wirtz CR, Halatsch ME, Karpel-Massler G[Volltext]
Meeting Abstract
(P055)
[Volltext]
Prognostic relevance of epilepsy at presentation in WHO grade III Glioma
Mercas BI, Heiland DH, Masalha W, Franco P, Beck J, Delev D, Schnell O[Volltext]
Meeting Abstract
(P056)
[Volltext]
IgG4-related hypertrophic pachymeningitis – a rare entity with elusive diagnosis
Esmaeilzadeh M, Polemikos M, Dadak M, Hartmann C, Hermann EJ, Krauss JK[Volltext]
Meeting Abstract
(P057)
[Volltext]
Ex vivo expanded NK cells with high cytotoxicity against cetuximab-opsonised primary glioblastoma cells
Michen S, Frosch J, Füssel M, Schackert G, Temme A[Volltext]
Meeting Abstract
(P058)
[Volltext]
Genome-wide methylation profiling of glioblastoma extracellular vesicle DNA allows tumour classifcation
Ricklefs FL, Maire C, Kolbe K, Holz M, Westphal M, Schüller U, Lamszus K[Volltext]
